Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

Oral Mucositis
Author Bios
Introduction
Etiology of Oral Mucositis
Currently selected section: Prevalence
Diagnosis
Treatment
Biological Mechanisms of Mucositis
Assessment Scale
Clinical Trial Design
Population Selection and Randomization
Data Collection and Assessment Measures
Quality Control Techniques
Anaysis and Presentation
Conclusion


Chapter 17: Oral Mucositis: Prevalence of Oral Mucositis and Associated Complications
        

About 75% of all patients undergoing bone marrow transplant develop symptomatic mucositis (Bellm et al., 1999). Chemotherapy produces mucositis in an estimated 40% of patients, while radiation therapy for tumors of the head and neck affects approximately 80% of patients. Symptoms can develop two to 10 days after the start of therapy and can last two to three weeks or more. Mucositis appears to be inversely proportional to the white blood cell count and platelet count (Seto et al., 1985).

Other oral complications that can arise during high-dose chemotherapy and radiation include:

Page 4 of 21
Previous Section